After a week spent trying to whip the 215 votes needed to pass the American Health Care Act, Republican leadership withdrew the bill from consideration Friday afternoon, sending the House into recess and leaving the Affordable Care Act in place.
The bill, the Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, would take several steps to improve transparency, Sen. Wyden, D-Ore., noted.
The Congressional Budget Office on Monday released its assessment of the American Health Care Act, the House GOP's proposal to replace Obamacare, and The Hill is outlining five of the biggest takeaways. Among them are the 24 million individuals who would be uninsured by 2026, with 14 million losing coverage next year, as well as the expected reduction in the federal deficit that the bill would bring about. The bill would also create extensive changes to Medicaid. (The Hill)
A partnership between HRA Pharma and Ibis Reproductive Health to begin an application for an OTC oral contraceptive to the Food and Drug Administration was recently announced, researchers noted.
Pharmacy patient care and collaboration across healthcare segments are vital to improving health and wellness nationwide, wrote Steve Anderson.
The Centers for Disease Control and Prevention recently collaborated with the Florida Department of Health to conduct additional analysis of locally acquired Zika cases, including analysis of resident travel patterns in Florida.
He served as senior advisor to President George W. Bush from 2000–2007 and as deputy chief of staff from 2004–2007.
Scott Gottlieb had served as a senior adviser at the Centers for Medicare and Medicaid Services during the Bush years and a decade ago served as a deputy commissioner at the FDA.
The ads state “Pharmacists provide access to better healthcare every day,” and “We’re here to provide access to health policy solutions.”
Of the three classes of medicine identified in the Canadian switch report, one is already available OTC in the U.S. and a second is expected to be under consideration for non-prescription status this year.